Table II.

Recommendations for individualizing a management approach for patients with acne sequelae, based on consensus

Recommendations

•The presence of acne-induced scarring (17/17), acne-induced macular hyperpigmentation (17/17), and acne-induced macular erythema (16/17) may prompt a more rapid escalation in treatment of active acne lesions •Selecting a treatment that reduces existing acne-induced macular hyperpigmentation (17/17) and acne-induced macular erythema (15/16) as well as active acne lesions is an important consideration when individualizing management in at-risk patients •Selecting a treatment that mitigates or reduces the risk of developing acne-induced macular hyperpigmentation in the future is an important consideration when individualizing management in at-risk patients (16/16) •Combination therapy (ie, consisting of 2 different topical treatments or a topical and oral treatment) that allows targeting of multiple pathways in acne pathophysiology should be considered to mitigate the risk of patients developing acne-induced macular hyperpigmentation (16/17) •When there is a risk of acne-induced macular hyperpigmentation, it is important to advise on use of sunscreen (17/17) •When selecting treatment for active acne lesions in patients with concomitant acne-induced scarring, the severity of scarring present (17/17), size of area affected (16/17), and the morphology of scars present (15/17) are important considerations